Hsin-fang Tu
R817, 8F, No. 1, Jen Ai Rd
TPQ, Taiwan
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Journal: Oncogene
Published: November 10, 2021
Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD.
Journal: Cancer research
Published: October 13, 2020
Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis.
Journal: Oncogene
Published: May 10, 2020
Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
Journal: Scientific reports
Published: February 14, 2020
HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis.
Journal: British journal of cancer
Published: May 16, 2018
Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase.
Journal: Oncotarget
Published: October 29, 2017
The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
Journal: Scientific reports
Published: December 22, 2016
Extensive evaluations of the cytotoxic effects of gold nanoparticles.
Journal: Biochimica et biophysica acta
Published: November 30, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026